Non-Small Cell Lung Cancer Market Analysis, Market Share, Market Research Report, Leading Companies
The growth of NSCLC Market is expected to increase due to increasing incident cases of NSCLC, continuous uptake of approved therapies mainly immune checkpoint inhibitors, increasing use of biomarker testing, probable entry of potential premium price emerging therapies and increasing awareness of mutations, among others. DelveInsight has introduced a new Market Insights , Epidemiology, and Market Forecast Report on " Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030 " to its portfolio. Key Highlights from report are: As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017. These cases are expected to grow with a significant CAGR in the study period 2017–2030. There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy,